International Price Regulations in the Pharmaceutical Sector:

Stefano Capri

Journal of Pharmaceutical Finance, Economics and Policy2007https://doi.org/10.1300/j371v15n02_03article
ABDC C
Weight
0.26

What the paper says

In this paper, we analyse the market for drugs in health care markets where third payers (an insurance company or a government agency) bear the cost and we suggest a common and transparent methodology to set the price for new drugs as well as active principles for which an alternative already exists. We argue that in this context, a bargaining approach is the most suitable instrument to describe the price-setting procedure and we show how this approach can be implemented. We argue that many of the systems that are used by western countries are in fact simplified applications of our model, the main difference usually being that the actual price-setting procedure is not as transparent as the one we propose. Copyright © by The Haworth Press, Inc. All rights reserved.

3 citations

Open paper page →

Cite this paper

https://doi.org/https://doi.org/10.1300/j371v15n02_03

Or copy a formatted citation

@article{stefano2007,
  title        = {{International Price Regulations in the Pharmaceutical Sector:}},
  author       = {Stefano Capri},
  journal      = {Journal of Pharmaceutical Finance, Economics and Policy},
  year         = {2007},
  doi          = {https://doi.org/https://doi.org/10.1300/j371v15n02_03},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

International Price Regulations in the Pharmaceutical Sector:

Flags are reviewed by the Arbiter methodology team within 5 business days.


Evidence weight

0.26

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.00 × 0.4 = 0.00
M · momentum0.20 × 0.15 = 0.03
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.